PIK3CA and carcinoma: The CN state of chromosomes 1, 11 or 16 as well as the PIK3CA mutation status of IDPs diagnosed in biopsies could be evaluated further as an assay to predict which subset of patients diagnosed with IDP could have the potential to develop carcinoma.